Use of alpha specific antibody BIBH1 in the treatment of cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 5, 2003
app pub date -
Apr 11, 2002
filing date -
Apr 12, 2001
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A method of treating a patient suffering from a pathological condition characterized by expression of FAP.alpha., the method comprising administering to the patient a therapeutically effective amount of an antibody which specifically binds to FAP.alpha.. A pharmaceutical composition comprising an antibody which specifically binds to FAP.alpha., wherein the antibody is radiolabeled with .sup.131I, .sup.90Y, .sup.186Re, or .sup.188Re, and wherein the antibody has specific activity of from about 0.5 to about 15 mCi/mg, is also provided.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully